Properties, production, and applications of camelid single-domain antibody fragments
Свойства, получение и применение однодоменных фрагментов антител верблюдовых
2007-08-17
SCID: 54.1/h6ubtvju
Discuss with AI
VHH Nanobodiesantigen bindingcamelid single-domain antibodiesmicrobial productiontherapeutic applications
Figures from the paper
Abstract (AI)
Camelids produce functional antibodies devoid of light chains of which the single N-terminal domain is fully capable of antigen binding. These single-domain antibody fragments (VHHs or Nanobodies) have several advantages for biotechnological applications. They are well expressed in microorganisms and have a high stability and solubility. Furthermore, they are well suited for construction of larger molecules and selection systems such as phage, yeast, or ribosome display. This minireview offers an overview of (1) their properties as compared to conventional antibodies, (2) their production in microorganisms, with a focus on yeasts, and (3) their therapeutic applications.
Key Findings
1
Camelids produce functional antibodies lacking light chains, whose single N-terminal VHH domain is independently capable of antigen binding.
2
Microbial production of VHHs is reviewed, with particular emphasis on yeast-based expression.
3
Their compact single-domain structure facilitates construction of larger molecules and use in phage, yeast, and ribosome display systems.
4
VHHs have potential therapeutic applications and differ in relevant properties from conventional antibodies.
5
VHHs, or Nanobodies, offer biotechnological advantages including strong expression in microorganisms, high stability, and high solubility.
Research Object
Camelid single-domain antibody fragments (VHHs or Nanobodies)
Research Subject
Their properties, microbial production—especially in yeasts—and therapeutic applications
Publication Details
Publication Date
2007-08-17
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest